Skip to content

Products
Experts
Competencies
About us
News
Career
Contact

[responsive_menu_pro]

US-FDA approval for Teriflunomide

PharmaZell gladly informs that we have received US-FDAs approval for our DMF-Type-II for our Product Teriflunomide.

Posted byredakteur16. August 202116. December 2022Posted inarchive-en

Imprint

Farmabios SPA, società con socio unico
Via Pavia, 1
27027 Gropello Cairoli (PV)
Italy
Phone: +39 0382 8191
Fax: +39 0382 815886
Email: info@farmabios.com
Managing Director: Ing. Mario Di Giacomo
Register Office: Via Pavia 1, 27027 Gropello Cairoli (Pavia) ITALY
Register No.: PAVIA 116689 – MVP 008496
VAT ID: 00180280182
Privacy Policy

Disclaimer:

The links on our website lead to other websites, the content and design of which we are not able to influence: as a measure of precaution we explicitly declare that we do neither examine nor support such other content and design and that therefore we reject any responsibility in this regard. On the other hand we do not guarantee the accessibility of useful websites linked by us.

© 2019-2022 Farmabios GmbH

Farmabios, Proudly powered by WordPress.

What can our Experts do for you?

Company Type:

Region:

Preferred Contact Option:

Request:

Δ

What can our Experts do for you?

Company Type:

Preferred Contact Option:

Request:

Δ

Give us your telephone number and we’ll call you back soon!

Δ

search for what

More results...

Generic filters

Hidden label

Exact matches only

Products
Experts
Competencies
About us
News
Career
Contact